Compile Data Set for Download or QSAR
maximum 50k data
Found 10 Enz. Inhib. hit(s) with all data for entry = 50010461
TargetSomatostatin receptor type 4(Homo sapiens (Human))
University Of California

Curated by ChEMBL
LigandPNGBDBM50095116((R)-1-(3-Amino-propyl)-6-(1H-indol-3-ylmethyl)-10-...)
Affinity DataIC50:  41nMAssay Description:Inhibitory concentration required for somatostatin 4 receptor in radioligand binding assay ([125I]-Tyr11-SRIF)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
University Of California

Curated by ChEMBL
LigandPNGBDBM50095116((R)-1-(3-Amino-propyl)-6-(1H-indol-3-ylmethyl)-10-...)
Affinity DataIC50:  41nMAssay Description:Inhibitory concentration required for somatostatin 5 receptor in radioligand binding assay ([125I]-Tyr11-SRIF)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(Homo sapiens (Human))
University Of California

Curated by ChEMBL
LigandPNGBDBM50095115((1R,9R)-5-(4-Amino-butyl)-2-(1H-indol-3-ylmethyl)-...)
Affinity DataIC50:  87nMAssay Description:Inhibitory concentration required for somatostatin 5 receptor in radioligand binding assay ([125I]-Tyr11-SRIF)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
University Of California

Curated by ChEMBL
LigandPNGBDBM50095116((R)-1-(3-Amino-propyl)-6-(1H-indol-3-ylmethyl)-10-...)
Affinity DataIC50:  275nMAssay Description:Inhibitory concentration required for somatostatin 2 receptor in radioligand binding assay ([125I]-Tyr11-SRIF)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1(Homo sapiens (Human))
University Of California

Curated by ChEMBL
LigandPNGBDBM50095116((R)-1-(3-Amino-propyl)-6-(1H-indol-3-ylmethyl)-10-...)
Affinity DataIC50:  407nMAssay Description:Inhibitory concentration required for somatostatin 1 receptor in radioligand binding assay ([125I]-Tyr11-SRIF)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1(Homo sapiens (Human))
University Of California

Curated by ChEMBL
LigandPNGBDBM50095115((1R,9R)-5-(4-Amino-butyl)-2-(1H-indol-3-ylmethyl)-...)
Affinity DataIC50:  501nMAssay Description:Inhibitory concentration required for somatostatin 1 receptor in radioligand binding assay ([125I]-Tyr11-SRIF)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 4(Homo sapiens (Human))
University Of California

Curated by ChEMBL
LigandPNGBDBM50095115((1R,9R)-5-(4-Amino-butyl)-2-(1H-indol-3-ylmethyl)-...)
Affinity DataIC50:  1.05E+3nMAssay Description:Inhibitory concentration required for somatostatin 4 receptor in radioligand binding assay ([125I]-Tyr11-SRIF)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
University Of California

Curated by ChEMBL
LigandPNGBDBM50095116((R)-1-(3-Amino-propyl)-6-(1H-indol-3-ylmethyl)-10-...)
Affinity DataIC50:  1.26E+3nMAssay Description:Inhibitory concentration required for somatostatin 3 receptor in radioligand binding assay ([125I]-Tyr11-SRIF)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(Homo sapiens (Human))
University Of California

Curated by ChEMBL
LigandPNGBDBM50095115((1R,9R)-5-(4-Amino-butyl)-2-(1H-indol-3-ylmethyl)-...)
Affinity DataIC50:  1.59E+3nMAssay Description:Inhibitory concentration required for somatostatin 2 receptor in radioligand binding assay ([125I]-Tyr11-SRIF)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(Homo sapiens (Human))
University Of California

Curated by ChEMBL
LigandPNGBDBM50095115((1R,9R)-5-(4-Amino-butyl)-2-(1H-indol-3-ylmethyl)-...)
Affinity DataIC50:  3.09E+3nMAssay Description:Inhibitory concentration required for somatostatin 3 receptor in radioligand binding assay ([125I]-Tyr11-SRIF)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed